Bolt Biotherapeutics amends Redwood City lease, accelerates expiry to December 2027
Bolt Biotherapeutics entered into a second amendment to its Redwood City, California lease on October 1, 2026. The company paid the landlord $1.0 million, agreed the landlord may draw the existing $1.5 million letter of credit in full, and accepted an earlier lease expiration date that would require a $4.5 million termination payment upon a financing or other strategic transaction, which could weigh on shareholders' cash and results.
Key points
- Company paid the landlord $1.0 million on signing the amendment
- Landlord may draw the existing $1.5 million letter of credit in its entirety
- Lease expiration accelerated to December 31, 2027, or earlier after a Corporate Transaction, with a $4.5 million termination payment due then
- Company says ongoing rent and operating expense obligations are not significant; accounting effects are still being evaluated
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.